Phase II study on lapatinib in advanced EGFR-positive chordoma. [electronic resource]
Producer: 20131211Description: 1931-1936 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Bone Neoplasms -- drug therapy
- Chordoma -- drug therapy
- Disease-Free Survival
- Drug Administration Schedule
- ErbB Receptors -- metabolism
- Female
- Humans
- Lapatinib
- Male
- Middle Aged
- Quinazolines -- administration & dosage
- Sacrum -- pathology
- Skull Base -- pathology
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.